UCB BIOSCIENCES, Inc.
29 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome (NCT07503444) | UCB BIOSCIENCES, Inc. | 2026-07-14 |
| A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants (NCT06679413) | UCB BIOSCIENCES, Inc. | 2024-12-04 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome (NCT06118255) | UCB BIOSCIENCES, Inc. | 2024-05-21 |
| An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency (NCT03845712) | UCB BIOSCIENCES, Inc. | 2019-07-05 |
Track UCB BIOSCIENCES, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.